Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (2096.HK) is an innovation and R&D-driven pharmaceutical company, with a mission of "providing today's patients with medicines of the future. It has established a National Key Laboratory of Translational Medicine and Innovative Drug Development. Simcere focuses on oncology, central nervous system disease and autoimmune disease therapeutic areas, with a diversified product portfolio and industry-leading capabilities. Its vigorous in-house R&D efforts and extensive R&D collaborations have made it a strategic cooperation partner with world leading pharmaceutical companies and biotechnology companies, in an effort to bring more global life science breakthroughs to China.